The only relevant diagnosis was the serous borderline ovarian tumor in the CHEK2 mutated patient, who underwent RRS for her genetic mutation as there was no preoperative suspicion of cancer, no personal history of BC or family history of EOC. The gene discussed is CHEK2; the disease is borderline ovarian serous tumor.